Bill117th CongressFiled Dec 1, 2021Health
H.R. 6101
Drug Price Transparency in Medicaid Act of 2021
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Dec 1, 2021)
Drug Price Transparency in Medicaid Act of 2021
This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.
What just happenedDec 2, 2021
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Carter, Earl L. "Buddy" [R-GA-1](R-GA)Sponsor
4 cosponsors1 D3 R
4cosponsors1committees4actions12subjects
- Introduced in HouseDec 1, 2021
- Dec 2, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Dec 1, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Dec 1, 2021IntroReferralIntro-H
Introduced in House
- Dec 1, 2021IntroReferral1000
Introduced in House